BTC $63,893.65 -2.30%
ETH $1,851.95 -2.16%
BNB $564.07 -0.85%
XRP $1.08 -2.44%
SOL $73.63 -3.05%
TRX $0.3292 -0.61%
DOGE $0.0692 -1.03%
ADA $0.1615 -3.79%
BCH $211.19 -0.43%
LINK $8.27 -3.02%
HYPE $57.02 -3.03%
AAVE $90.76 -5.57%
SUI $0.7023 -5.45%
XLM $0.1766 -4.06%
ZEC $474.05 -7.17%
BTC $63,893.65 -2.30%
ETH $1,851.95 -2.16%
BNB $564.07 -0.85%
XRP $1.08 -2.44%
SOL $73.63 -3.05%
TRX $0.3292 -0.61%
DOGE $0.0692 -1.03%
ADA $0.1615 -3.79%
BCH $211.19 -0.43%
LINK $8.27 -3.02%
HYPE $57.02 -3.03%
AAVE $90.76 -5.57%
SUI $0.7023 -5.45%
XLM $0.1766 -4.06%
ZEC $474.05 -7.17%

Public company Leap Therapeutics completes $58,888,888 private placement to initiate digital asset financial strategy

2025-10-09 19:13:53
Collection

ChainCatcher news, biotechnology company Leap Therapeutics (NASDAQ: LPTX) announced that it has completed the previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to initiate its digital asset financial strategy.

Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy.

app_icon
ChainCatcher Building the Web3 world with innovations.